Seeing Is Believing
ATRA is currently covered by 9 analysts with an average price target of $12.26. This is a potential upside of $11.55 (1626.76%) from yesterday's end of day stock price of $0.71.
Atara Biotherapeutics's activity chart (see below) currently has 67 price targets and 67 ratings on display. The stock rating distribution of ATRA is 57.14% BUY, 23.81% SELL and 19.05% HOLD.
Analysts average stock forecasts to be materialized ratio is 32.36% with an average time for these price targets to be met of 93 days.
Highest price target for ATRA is $28, Lowest price target is $1, average price target is $12.26.
Most recent stock forecast was given by SALIM SYED from MIZUHO on 09-Nov-2023. First documented stock forecast 03-Dec-2015.
Currently out of the existing stock ratings of ATRA, 12 are a BUY (57.14%), 5 are a SELL (23.81%), 4 are a HOLD (19.05%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
1
$0.21 (26.58%)
5 months 15 days ago
1/7 (14.29%)
$0.76 (316.67%)
85
Sell
1.4
$0.61 (77.22%)
3
8 months 3 days ago
13/15 (86.67%)
$-0.01 (-0.71%)
298
Buy
28
$26.52 (1791.89%)
10 months 10 days ago
1/4 (25%)
$14.24 (361.67%)
123
Buy
11 months 15 days ago
0/3 (0%)
$62.36 (398.72%)
Sell
1 years 8 months 15 days ago
3/3 (100%)
$0.54 (4.01%)
12
What is ATRA (Atara Biotherapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ATRA (Atara Biotherapeutics) with a proven track record?
Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?